Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?

Respiratory Medicine

Volumn 97, Issue 3, 2003, Pages 264-272

  Ringæk, Thomas ^a   Viskum, K ^b  

^a Mental Health Services CPH   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Asthma; COPD; Ipratropium; Survival

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL PLUS IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE; PREDNISOLONE; SALBUTAMOL; STEROID; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; BREATHING RATE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; COR PULMONALE; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING HABIT;

EID: 0037370244     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2003.1423     Document Type: Article

References (22)

1. Guite HF, Dundas R, Burney PGJ. Risk factors for death from asthma, chronic obstructive pulmonary disease and cardiovascular disease after a hospital admission for asthma. Thorax 1999; 54: 301-307.
2. Sin DD, Tu JV. Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease. Thorax 2000; 55: 194-197.
3. Rosengren A, Wilhelmsen L. Respiratory symptoms and long-term risk of death from cardiovascular disease, cancer and other causes in Swedish men. Int J Epidemiol 1998; 27: 962-969.
4. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 1856-1861.
5. Speizer FE, Fay ME, Dockery DW, et al. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 1989: 140: S49-S55.
6. Tockman MS, Comstock GW. Respiratory risk factors and mortality: longitudinal studies in Washington county, Maryland. Am Rev Respir Dis 1989; 140: S56-S63.
7. Ulrik CS, Frederiksen J. Mortality and markers of risk of asthma death among 1075 outpatients with asthma. Chest 1995; 108: 10-15.
8. Ryan G, Musk AW, Perera DM, et al. Risk factors for death in patients admitted to hospital with asthma: a follow-up study. Aust NZJ Med 1991; 21: 681-685.
9. Krzyzanowski M, Wysocki M. The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow study. Int J Epidemiol 1986; 15: 56-64.
10. Lange P. Groth S, Nyboe J, et al. Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects. J Int Med 1989; 226: 25-32.
11. Crane J, Pearce N, Burgess C, et al. Markers of risk of asthma death or readmission in the 12 months following hospital admission for asthma. Int J Epidemiol 1992; 21: 737-744.
12. Gray-Donald K, Gibbons L, Shapiro SH, et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 961-966.
13. Grainger J, Woodman K, Pearce N, et al. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax 1991; 46: 105-111.
14. I. The Lung Health Study. JAMA 1994; 272: 1497-1505.
15. Kesten S, Rebuck AS, Chapman KR. Trends in asthma and chronic obstructive pulmonary disease therapy in Canada, 1985 to 1990. J Allergy Clin Immunol 1993; 92: 499-506.
16. Garrett JE, Lanes SF, Kolbe J, et al. Risk of severe life threatening asthma and β agonist type: an example of confounding by severity. Thorax 1996; 51: 1093-1099.
17. Spitzer WO, Suissa S, Ernst P, et al. The use of β-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501-506.
18. Alderson M, Loy RM. Mortality from respiratory disease at follow-up of patients with asthma. Br J Dis Chest 1977; 71: 198-202.
19. Markowe HLJ, Bulpitt CJ, Shipley MJ, et al. Prognosis in adult asthma: a national study. BMJ 1987; 295: 949-952.
20. Lange P, Ulrik CS, Vestbo J. Mortality in adults with self-reported asthma. Copenhagen City Heart Study Group. Lancet 1996; 347: 1285-1289.
21. Huovinen E, Kaprio J, Vesterinen E, et al. Mortality of adults with asthma: a prospective cohort study. Thorax 1997; 52: 49-54.
22. Ulrik CS, Backer V, Dirksen A. Mortality and decline in lung function in 213 adults with bronchial asthma: a ten-year follow up. J Asthma 1992; 29: 29-38.